Corona vaccine developer Curevac gives the go-ahead for IPO

Lettering from Curevac The Tübingen-based company intends to use the money from the IPO to finance the development of its corona vaccine candidate until the … Read more

Tübingen-based biotech company Immatics makes its debut at Nasdaq

Frankfurt The German biotech company Immatics has now significantly strengthened its financial base with a listing on the US technology exchange Nasdaq. The Tübingen-based company … Read more

Tübingen-based biotech company Immatics makes its debut at Nasdaq

Frankfurt The German biotech company Immatics has now significantly strengthened its financial base with a listing on the US technology exchange Nasdaq. The Tübingen-based company … Read more

Tübingen-based biotech company Immatics makes its debut at Nasdaq

Frankfurt The German biotech company Immatics has now significantly strengthened its financial base with a listing on the US technology exchange Nasdaq. The Tübingen-based company … Read more

Tübingen-based biotech company Immatics makes its debut at Nasdaq

Frankfurt The German biotech company Immatics has now significantly strengthened its financial base with a listing on the US technology exchange Nasdaq. The Tübingen-based company … Read more